HC5 Stock Overview
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
+ 2 more risks
Healthpeak Properties, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$17.30 |
| 52 Week High | US$20.20 |
| 52 Week Low | US$14.40 |
| Beta | 1.02 |
| 1 Month Change | 7.45% |
| 3 Month Change | -2.81% |
| 1 Year Change | -7.98% |
| 3 Year Change | -37.61% |
| 5 Year Change | -35.04% |
| Change since IPO | -39.30% |
Recent News & Updates
Recent updates
Shareholder Returns
| HC5 | DE Health Care REITs | DE Market | |
|---|---|---|---|
| 7D | 2.4% | 0% | 0% |
| 1Y | -8.0% | 0% | 0% |
Return vs Industry: HC5 exceeded the German Health Care REITs industry which returned -17.3% over the past year.
Return vs Market: HC5 underperformed the German Market which returned 2.2% over the past year.
Price Volatility
| HC5 volatility | |
|---|---|
| HC5 Average Weekly Movement | 4.0% |
| Health Care REITs Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in DE Market | 0% |
| 10% least volatile stocks in DE Market | 0% |
Stable Share Price: HC5 has not had significant price volatility in the past 3 months.
Volatility Over Time: HC5's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | 193 | Scott Brinker | www.healthpeak.com |
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Healthpeak Properties, Inc. Fundamentals Summary
| HC5 fundamental statistics | |
|---|---|
| Market cap | €12.36b |
| Earnings (TTM) | €284.32m |
| Revenue (TTM) | €2.04b |
43.4x
P/E Ratio6.1x
P/S RatioIs HC5 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HC5 income statement (TTM) | |
|---|---|
| Revenue | US$2.18b |
| Cost of Revenue | US$902.66m |
| Gross Profit | US$1.28b |
| Other Expenses | US$974.06m |
| Earnings | US$304.28m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 25, 2024
| Earnings per share (EPS) | 0.43 |
| Gross Margin | 58.61% |
| Net Profit Margin | 13.95% |
| Debt/Equity Ratio | 99.3% |
How did HC5 perform over the long term?
See historical performance and comparison